Group 1 - In 2025, discussions around AI contributed to the stock market reaching new all-time highs, while in 2026, AI is negatively impacting stocks outside of "old economy" companies [1] Group 2 - Gary Alexander has extensive experience in technology companies, having worked on Wall Street and in Silicon Valley, and has been a contributor to Seeking Alpha since 2017 [2]

Group 1 - NVIDIA (NVDA) is set to report its fourth-quarter earnings on February 25 after the market closes [2] - The company is considered the primary engine of the artificial intelligence revolution, making its results a key indicator for the industry [2]

Core Viewpoint - The event features a presentation led by Kannan Venkateshwar from Barclays, focusing on North American cable, telecom, and media research, with participation from Verizon's CFO, Tony Skiadas [1]. Group 1 - Kannan Venkateshwar is the leader of the North American cable, telecom, and media research at Barclays [1]. - Tony Skiadas, CFO of Verizon, is participating in the event, indicating a focus on Verizon's financial and operational insights [1].

CTI initiated coverage on CTS Corporation ( CTS ) previously. Revisiting our investment thesis after 3 fiscal years, we continue to maintain Overweight on CTS with a Buy rating of $62.80, implying a c.16% upside as of the date ofWe are a Singapore-based research team that seeks to exploit market inefficiencies and source for undervalued opportunities to generate long-term alpha. Unafraid to disagree with the consensus, we strive to generate investment theses based on attractive valuations across our investm ...

Core Insights - The article does not provide specific insights or analysis regarding any companies or industries, focusing instead on disclaimers and disclosures [1][2] Group 1 - There is no stock, option, or similar derivative position in any of the companies mentioned [1] - The article expresses personal opinions and is not receiving compensation beyond Seeking Alpha [1] - The authors are not licensed or certified by any institute or regulatory body [2]

I want to empower Investors, to make as much money, from both income and capital appreciation, with as little risk as possible, through my coverage of dividend, growth, and value companies. This broad coverage allows for discovering new, exciting ideas while covering what makes up reader's portfolios already."In giving (not investment) advice seek to help, not to please, your friend." - SolonMy investing style:Selective Investor looking for opportunities with a good risk-adjusted ROI. For dividend investing ...

Core Insights - The article emphasizes the importance of creating engaging financial content that is accessible and relevant to everyday investors, highlighting the role of narrative in presenting financial data [1] Group 1: Content Creation - The company specializes in producing written content in various formats, including articles, blogs, emails, and social media, aimed at financial advisors and investment firms [1] - There is a focus on thematic investing, market events, and client education, with an aim to relate to everyday investors in a concise manner [1] - The use of empirical data and charts is highlighted as a method to create evidence-based narratives that effectively communicate financial concepts [1] Group 2: Market Analysis - The company expresses enthusiasm for analyzing various asset classes, including stocks, bonds, commodities, currencies, and cryptocurrencies, indicating a broad interest in macro drivers affecting these markets [1] - There is an emphasis on producing content that is not only informative but also engaging, utilizing SEO strategies and specific style guides when appropriate [1]

分组1 - Myriad Genetics, Inc. reported a strong earnings beat for Q4 2025, with Non-GAAP EPS at $0.04, surpassing consensus estimates [1] - The stock price increased approximately 25% in pre-market trading following the earnings announcement [1] 分组2 - The article emphasizes the importance of combining scientific expertise with financial analysis in the biotech sector [1] - The focus is on identifying innovative biotechnology companies that are developing unique therapies and technologies [1] - The analysis aims to evaluate the science behind drug candidates, competitive landscape, clinical trial design, and market opportunities while considering financial fundamentals [1]

2025 was certainly a strange year for Energy Transfer’s unitholders, as units lost around 16% in value, though 2026 saw an already strong appreciation. I’ve been a long-time bull on ET , and IAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. Basically, anything that has been u ...

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TSLX, ARCC, BXSL, OBDC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given a ...